nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP2D6—endogenous depression	0.794	1	CbGaD
Lansoprazole—ATP4B—endocrine gland—endogenous depression	0.00577	0.0644	CbGeAlD
Lansoprazole—MAPT—pituitary gland—endogenous depression	0.00436	0.0488	CbGeAlD
Lansoprazole—ATP4A—adrenal cortex—endogenous depression	0.00401	0.0448	CbGeAlD
Lansoprazole—MAPT—adrenal gland—endogenous depression	0.0039	0.0436	CbGeAlD
Lansoprazole—MAPT—midbrain—endogenous depression	0.00385	0.043	CbGeAlD
Lansoprazole—MAPT—thyroid gland—endogenous depression	0.00376	0.042	CbGeAlD
Lansoprazole—ATP4A—cardiovascular system—endogenous depression	0.00366	0.0409	CbGeAlD
Lansoprazole—CYP4A11—endocrine gland—endogenous depression	0.00311	0.0348	CbGeAlD
Lansoprazole—MAPT—cerebellum—endogenous depression	0.00298	0.0333	CbGeAlD
Lansoprazole—ATP4A—adrenal gland—endogenous depression	0.00289	0.0323	CbGeAlD
Lansoprazole—Rabeprazole—CYP2D6—endogenous depression	0.00252	0.551	CrCbGaD
Lansoprazole—ATP4A—endocrine gland—endogenous depression	0.00251	0.028	CbGeAlD
Lansoprazole—MAPT—brain—endogenous depression	0.00242	0.027	CbGeAlD
Lansoprazole—ATP4A—nervous system—endogenous depression	0.00235	0.0263	CbGeAlD
Lansoprazole—ATP4A—central nervous system—endogenous depression	0.00226	0.0253	CbGeAlD
Lansoprazole—ATP4A—cerebellum—endogenous depression	0.00221	0.0247	CbGeAlD
Lansoprazole—CYP2C18—endocrine gland—endogenous depression	0.00206	0.0231	CbGeAlD
Lansoprazole—Omeprazole—CYP2D6—endogenous depression	0.00205	0.449	CrCbGaD
Lansoprazole—ATP4A—brain—endogenous depression	0.0018	0.0201	CbGeAlD
Lansoprazole—CYP1B1—cardiovascular system—endogenous depression	0.00146	0.0163	CbGeAlD
Lansoprazole—CYP1B1—pituitary gland—endogenous depression	0.00129	0.0144	CbGeAlD
Lansoprazole—ABCG2—adrenal cortex—endogenous depression	0.00119	0.0133	CbGeAlD
Lansoprazole—CYP1B1—adrenal gland—endogenous depression	0.00115	0.0129	CbGeAlD
Lansoprazole—CYP1B1—thyroid gland—endogenous depression	0.00111	0.0124	CbGeAlD
Lansoprazole—CYP1B1—endocrine gland—endogenous depression	0.000999	0.0112	CbGeAlD
Lansoprazole—CYP2C9—cardiovascular system—endogenous depression	0.000991	0.0111	CbGeAlD
Lansoprazole—CYP2C8—pituitary gland—endogenous depression	0.000988	0.011	CbGeAlD
Lansoprazole—ABCG2—pituitary gland—endogenous depression	0.000961	0.0107	CbGeAlD
Lansoprazole—CYP1B1—nervous system—endogenous depression	0.000935	0.0105	CbGeAlD
Lansoprazole—CYP2D6—brainstem—endogenous depression	0.000911	0.0102	CbGeAlD
Lansoprazole—CYP1A1—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.000907	0.00813	CbGpPWpGaD
Lansoprazole—CYP2C18—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000905	0.00811	CbGpPWpGaD
Lansoprazole—CYP1B1—central nervous system—endogenous depression	0.0009	0.0101	CbGeAlD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.000891	0.00798	CbGpPWpGaD
Lansoprazole—CYP1B1—cerebellum—endogenous depression	0.00088	0.00984	CbGeAlD
Lansoprazole—CYP2D6—forebrain—endogenous depression	0.000879	0.00983	CbGeAlD
Lansoprazole—CYP2C19—endocrine gland—endogenous depression	0.000877	0.0098	CbGeAlD
Lansoprazole—CYP2C9—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000876	0.00785	CbGpPWpGaD
Lansoprazole—CYP1B1—Endogenous sterols—POMC—endogenous depression	0.000869	0.00778	CbGpPWpGaD
Lansoprazole—ABCG2—adrenal gland—endogenous depression	0.000858	0.00959	CbGeAlD
Lansoprazole—ABCG2—midbrain—endogenous depression	0.000847	0.00947	CbGeAlD
Lansoprazole—ABCG2—thyroid gland—endogenous depression	0.000828	0.00925	CbGeAlD
Lansoprazole—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000823	0.00738	CbGpPWpGaD
Lansoprazole—CYP1B1—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000813	0.00728	CbGpPWpGaD
Lansoprazole—CYP1A2—thyroid gland—endogenous depression	0.000797	0.00891	CbGeAlD
Lansoprazole—MAPT—BDNF signaling pathway—BDNF—endogenous depression	0.000795	0.00713	CbGpPWpGaD
Lansoprazole—CYP1A1—thyroid gland—endogenous depression	0.000786	0.00878	CbGeAlD
Lansoprazole—CYP4A11—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000779	0.00698	CbGpPWpGaD
Lansoprazole—CYP1A2—Xenobiotics—CYP2D6—endogenous depression	0.000779	0.00698	CbGpPWpGaD
Lansoprazole—CYP2C8—endocrine gland—endogenous depression	0.000765	0.00855	CbGeAlD
Lansoprazole—CYP1A2—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000749	0.00671	CbGpPWpGaD
Lansoprazole—CYP2C19—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.000742	0.00665	CbGpPWpGaD
Lansoprazole—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.000718	0.00644	CbGpPWpGaD
Lansoprazole—CYP1A2—endocrine gland—endogenous depression	0.000716	0.008	CbGeAlD
Lansoprazole—CYP1B1—brain—endogenous depression	0.000715	0.00799	CbGeAlD
Lansoprazole—CYP1A1—endocrine gland—endogenous depression	0.000706	0.00789	CbGeAlD
Lansoprazole—MAPT—MAPK Signaling Pathway—BDNF—endogenous depression	0.000703	0.0063	CbGpPWpGaD
Lansoprazole—CYP1A1—Melatonin metabolism and effects—MAOA—endogenous depression	0.000683	0.00612	CbGpPWpGaD
Lansoprazole—CYP2C18—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000681	0.0061	CbGpPWpGaD
Lansoprazole—CYP2C9—endocrine gland—endogenous depression	0.00068	0.0076	CbGeAlD
Lansoprazole—CYP1B1—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000667	0.00598	CbGpPWpGaD
Lansoprazole—CYP1A1—Oxidative Stress—MAOA—endogenous depression	0.000664	0.00595	CbGpPWpGaD
Lansoprazole—CYP1A1—nervous system—endogenous depression	0.000661	0.00739	CbGeAlD
Lansoprazole—CYP1A2—Tryptophan metabolism—TPH1—endogenous depression	0.00066	0.00591	CbGpPWpGaD
Lansoprazole—ABCG2—cerebellum—endogenous depression	0.000655	0.00732	CbGeAlD
Lansoprazole—CYP1A2—Estrogen metabolism—COMT—endogenous depression	0.000642	0.00575	CbGpPWpGaD
Lansoprazole—CYP1A1—central nervous system—endogenous depression	0.000637	0.00711	CbGeAlD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000635	0.00569	CbGpPWpGaD
Lansoprazole—ABCB1—forebrain—endogenous depression	0.000633	0.00707	CbGeAlD
Lansoprazole—CYP4A11—NRF2 pathway—SLC6A4—endogenous depression	0.000627	0.00562	CbGpPWpGaD
Lansoprazole—CYP4A11—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000626	0.00561	CbGpPWpGaD
Lansoprazole—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.000601	0.00538	CbGpPWpGaD
Lansoprazole—ABCB1—adrenal cortex—endogenous depression	0.000586	0.00655	CbGeAlD
Lansoprazole—CYP1A2—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.000578	0.00518	CbGpPWpGaD
Lansoprazole—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000578	0.00518	CbGpPWpGaD
Lansoprazole—CYP2C19—Melatonin metabolism and effects—MAOA—endogenous depression	0.000559	0.005	CbGpPWpGaD
Lansoprazole—CYP4A11—Biological oxidations—CYP2D6—endogenous depression	0.00055	0.00493	CbGpPWpGaD
Lansoprazole—CYP2C8—brain—endogenous depression	0.000547	0.00612	CbGeAlD
Lansoprazole—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000547	0.0049	CbGpPWpGaD
Lansoprazole—ABCB1—cardiovascular system—endogenous depression	0.000535	0.00598	CbGeAlD
Lansoprazole—ABCG2—brain—endogenous depression	0.000532	0.00595	CbGeAlD
Lansoprazole—CYP3A4—endocrine gland—endogenous depression	0.000518	0.00579	CbGeAlD
Lansoprazole—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000514	0.0046	CbGpPWpGaD
Lansoprazole—CYP2D6—endocrine gland—endogenous depression	0.00051	0.0057	CbGeAlD
Lansoprazole—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.000509	0.00456	CbGpPWpGaD
Lansoprazole—CYP4A11—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000507	0.00455	CbGpPWpGaD
Lansoprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000507	0.00454	CbGpPWpGaD
Lansoprazole—CYP1A1—brain—endogenous depression	0.000505	0.00565	CbGeAlD
Lansoprazole—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000502	0.0045	CbGpPWpGaD
Lansoprazole—CYP1A1—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.0005	0.00448	CbGpPWpGaD
Lansoprazole—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.000495	0.00444	CbGpPWpGaD
Lansoprazole—CYP3A4—nervous system—endogenous depression	0.000485	0.00542	CbGeAlD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.000482	0.00432	CbGpPWpGaD
Lansoprazole—CYP2C18—Biological oxidations—CYP2D6—endogenous depression	0.000481	0.00431	CbGpPWpGaD
Lansoprazole—CYP2D6—nervous system—endogenous depression	0.000477	0.00533	CbGeAlD
Lansoprazole—CYP2C18—Metapathway biotransformation—CYP2D6—endogenous depression	0.000474	0.00425	CbGpPWpGaD
Lansoprazole—ABCB1—pituitary gland—endogenous depression	0.000474	0.00529	CbGeAlD
Lansoprazole—CYP3A4—central nervous system—endogenous depression	0.000467	0.00522	CbGeAlD
Lansoprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000465	0.00416	CbGpPWpGaD
Lansoprazole—CYP2D6—central nervous system—endogenous depression	0.00046	0.00514	CbGeAlD
Lansoprazole—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000459	0.00411	CbGpPWpGaD
Lansoprazole—CYP2D6—cerebellum—endogenous depression	0.000449	0.00502	CbGeAlD
Lansoprazole—CYP2C18—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000444	0.00397	CbGpPWpGaD
Lansoprazole—CYP1A2—Melatonin metabolism and effects—MAOA—endogenous depression	0.000435	0.0039	CbGpPWpGaD
Lansoprazole—ABCB1—adrenal gland—endogenous depression	0.000423	0.00473	CbGeAlD
Lansoprazole—ABCB1—midbrain—endogenous depression	0.000418	0.00467	CbGeAlD
Lansoprazole—CYP4A11—Biological oxidations—COMT—endogenous depression	0.000417	0.00374	CbGpPWpGaD
Lansoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000415	0.00372	CbGpPWpGaD
Lansoprazole—CYP4A11—Biological oxidations—MAOA—endogenous depression	0.000414	0.00371	CbGpPWpGaD
Lansoprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000411	0.00368	CbGpPWpGaD
Lansoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000409	0.00367	CbGpPWpGaD
Lansoprazole—ABCB1—thyroid gland—endogenous depression	0.000408	0.00456	CbGeAlD
Lansoprazole—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000403	0.00361	CbGpPWpGaD
Lansoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000378	0.00339	CbGpPWpGaD
Lansoprazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000377	0.00338	CbGpPWpGaD
Lansoprazole—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000373	0.00335	CbGpPWpGaD
Lansoprazole—ABCB1—endocrine gland—endogenous depression	0.000367	0.0041	CbGeAlD
Lansoprazole—CYP2D6—brain—endogenous depression	0.000365	0.00408	CbGeAlD
Lansoprazole—CYP2C18—Biological oxidations—COMT—endogenous depression	0.000364	0.00327	CbGpPWpGaD
Lansoprazole—CYP2C18—Biological oxidations—MAOA—endogenous depression	0.000362	0.00324	CbGpPWpGaD
Lansoprazole—CYP2C18—Metapathway biotransformation—COMT—endogenous depression	0.000359	0.00322	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—CYP2D6—endogenous depression	0.000355	0.00318	CbGpPWpGaD
Lansoprazole—CYP1B1—Metapathway biotransformation—CYP2D6—endogenous depression	0.00035	0.00313	CbGpPWpGaD
Lansoprazole—ABCB1—nervous system—endogenous depression	0.000343	0.00384	CbGeAlD
Lansoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000336	0.00301	CbGpPWpGaD
Lansoprazole—ABCB1—central nervous system—endogenous depression	0.000331	0.00369	CbGeAlD
Lansoprazole—CYP1B1—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000327	0.00293	CbGpPWpGaD
Lansoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000323	0.0029	CbGpPWpGaD
Lansoprazole—ABCB1—cerebellum—endogenous depression	0.000323	0.00361	CbGeAlD
Lansoprazole—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000319	0.00286	CbGpPWpGaD
Lansoprazole—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000309	0.00277	CbGpPWpGaD
Lansoprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000307	0.00275	CbGpPWpGaD
Lansoprazole—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000284	0.00254	CbGpPWpGaD
Lansoprazole—CYP4A11—Biological oxidations—POMC—endogenous depression	0.00027	0.00242	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—COMT—endogenous depression	0.000269	0.00241	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—MAOA—endogenous depression	0.000267	0.00239	CbGpPWpGaD
Lansoprazole—CYP1B1—Metapathway biotransformation—COMT—endogenous depression	0.000265	0.00237	CbGpPWpGaD
Lansoprazole—ABCB1—brain—endogenous depression	0.000262	0.00293	CbGeAlD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000262	0.00235	CbGpPWpGaD
Lansoprazole—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000253	0.00227	CbGpPWpGaD
Lansoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00025	0.00224	CbGpPWpGaD
Lansoprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000248	0.00223	CbGpPWpGaD
Lansoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000246	0.00221	CbGpPWpGaD
Lansoprazole—CYP2C18—Biological oxidations—POMC—endogenous depression	0.000236	0.00211	CbGpPWpGaD
Lansoprazole—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000233	0.00209	CbGpPWpGaD
Lansoprazole—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000231	0.00207	CbGpPWpGaD
Lansoprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000228	0.00204	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL10—endogenous depression	0.000225	0.00202	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—CYP2D6—endogenous depression	0.000218	0.00196	CbGpPWpGaD
Lansoprazole—CYP1A1—Metapathway biotransformation—CYP2D6—endogenous depression	0.000215	0.00193	CbGpPWpGaD
Lansoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000203	0.00182	CbGpPWpGaD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000202	0.00181	CbGpPWpGaD
Lansoprazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000201	0.0018	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—CYP2D6—endogenous depression	0.0002	0.00179	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—CYP2D6—endogenous depression	0.000197	0.00177	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000197	0.00177	CbGpPWpGaD
Lansoprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000187	0.00168	CbGpPWpGaD
Lansoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000185	0.00166	CbGpPWpGaD
Lansoprazole—CYP2C8—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000185	0.00165	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase II conjugation—COMT—endogenous depression	0.00018	0.00162	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—CYP2D6—endogenous depression	0.000179	0.0016	CbGpPWpGaD
Lansoprazole—CYP2C19—Metapathway biotransformation—CYP2D6—endogenous depression	0.000176	0.00158	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—POMC—endogenous depression	0.000174	0.00156	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—COMT—endogenous depression	0.000165	0.00148	CbGpPWpGaD
Lansoprazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000165	0.00148	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—MAOA—endogenous depression	0.000164	0.00147	CbGpPWpGaD
Lansoprazole—CYP1A1—Metapathway biotransformation—COMT—endogenous depression	0.000163	0.00146	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—CYP2D6—endogenous depression	0.000163	0.00146	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—CYP2D6—endogenous depression	0.000161	0.00144	CbGpPWpGaD
Lansoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000158	0.00142	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—TPH1—endogenous depression	0.000155	0.00139	CbGpPWpGaD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000152	0.00136	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—COMT—endogenous depression	0.000152	0.00136	CbGpPWpGaD
Lansoprazole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000152	0.00136	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—MAOA—endogenous depression	0.000151	0.00135	CbGpPWpGaD
Lansoprazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00015	0.00135	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—COMT—endogenous depression	0.00015	0.00134	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—CYP2D6—endogenous depression	0.000139	0.00125	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—CYP2D6—endogenous depression	0.000137	0.00123	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—TPH1—endogenous depression	0.000136	0.00122	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—COMT—endogenous depression	0.000135	0.00121	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—MAOA—endogenous depression	0.000134	0.0012	CbGpPWpGaD
Lansoprazole—CYP2C19—Metapathway biotransformation—COMT—endogenous depression	0.000134	0.0012	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000128	0.00115	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—COMT—endogenous depression	0.000125	0.00112	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—MAOA—endogenous depression	0.000124	0.00111	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—COMT—endogenous depression	0.000123	0.00111	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	0.000123	0.0011	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—MAOA—endogenous depression	0.000123	0.0011	CbGpPWpGaD
Lansoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000122	0.0011	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—COMT—endogenous depression	0.000122	0.00109	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—TPH2—endogenous depression	0.000118	0.00105	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CACNB2—endogenous depression	0.000118	0.00105	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000116	0.00104	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—DPYD—endogenous depression	0.000116	0.00104	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CACNA1C—endogenous depression	0.000108	0.000964	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	0.000107	0.000963	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—POMC—endogenous depression	0.000107	0.000958	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	0.000106	0.000949	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—COMT—endogenous depression	0.000106	0.000945	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—MAOA—endogenous depression	0.000105	0.000939	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—COMT—endogenous depression	0.000104	0.000932	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000104	0.000927	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CACNB2—endogenous depression	0.000103	0.000922	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—TPH2—endogenous depression	0.000103	0.000922	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—DPYD—endogenous depression	0.000101	0.000907	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—TPH1—endogenous depression	0.0001	0.000897	CbGpPWpGaD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	9.91e-05	0.000888	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—POMC—endogenous depression	9.81e-05	0.000879	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CYP2D6—endogenous depression	9.41e-05	0.000843	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CACNA1C—endogenous depression	9.41e-05	0.000843	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—TPH1—endogenous depression	9.11e-05	0.000816	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—POMC—endogenous depression	8.75e-05	0.000784	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP2D6—endogenous depression	8.22e-05	0.000737	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—COMT—endogenous depression	8.14e-05	0.00073	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—MAOA—endogenous depression	8.09e-05	0.000724	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—POMC—endogenous depression	8.05e-05	0.000721	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	8.03e-05	0.00072	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—POMC—endogenous depression	7.98e-05	0.000715	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—TPH2—endogenous depression	7.58e-05	0.00068	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CACNB2—endogenous depression	7.58e-05	0.00068	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—DPYD—endogenous depression	7.46e-05	0.000669	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—COMT—endogenous depression	7.13e-05	0.000639	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—MAOA—endogenous depression	7.08e-05	0.000634	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CACNA1C—endogenous depression	6.94e-05	0.000621	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—TPH2—endogenous depression	6.9e-05	0.000618	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CACNB2—endogenous depression	6.9e-05	0.000618	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—POMC—endogenous depression	6.82e-05	0.000611	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—DPYD—endogenous depression	6.79e-05	0.000608	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	6.67e-05	0.000598	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CACNA1C—endogenous depression	6.31e-05	0.000565	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—COMT—endogenous depression	6.23e-05	0.000558	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—MAOA—endogenous depression	6.19e-05	0.000554	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TPH1—endogenous depression	6.16e-05	0.000552	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP2D6—endogenous depression	6.06e-05	0.000543	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TPH1—endogenous depression	5.65e-05	0.000506	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP2D6—endogenous depression	5.52e-05	0.000494	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—POMC—endogenous depression	5.26e-05	0.000472	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TPH1—endogenous depression	5.04e-05	0.000452	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TPH1—endogenous depression	4.92e-05	0.000441	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TPH2—endogenous depression	4.67e-05	0.000418	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CACNB2—endogenous depression	4.67e-05	0.000418	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TPH1—endogenous depression	4.64e-05	0.000416	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—POMC—endogenous depression	4.61e-05	0.000413	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TPH1—endogenous depression	4.6e-05	0.000412	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—COMT—endogenous depression	4.6e-05	0.000412	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—DPYD—endogenous depression	4.6e-05	0.000412	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—MAOA—endogenous depression	4.56e-05	0.000409	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TPH2—endogenous depression	4.28e-05	0.000384	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CACNB2—endogenous depression	4.28e-05	0.000384	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CACNA1C—endogenous depression	4.27e-05	0.000383	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—DPYD—endogenous depression	4.21e-05	0.000377	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—COMT—endogenous depression	4.18e-05	0.000375	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MAOA—endogenous depression	4.15e-05	0.000372	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	4.11e-05	0.000368	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—POMC—endogenous depression	4.03e-05	0.000361	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TPH1—endogenous depression	3.93e-05	0.000352	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CACNA1C—endogenous depression	3.92e-05	0.000351	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TPH2—endogenous depression	3.82e-05	0.000342	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CACNB2—endogenous depression	3.82e-05	0.000342	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—endogenous depression	3.77e-05	0.000337	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—DPYD—endogenous depression	3.76e-05	0.000337	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP2D6—endogenous depression	3.73e-05	0.000335	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TPH2—endogenous depression	3.73e-05	0.000334	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CACNB2—endogenous depression	3.73e-05	0.000334	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—DPYD—endogenous depression	3.67e-05	0.000329	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TPH2—endogenous depression	3.52e-05	0.000315	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CACNB2—endogenous depression	3.52e-05	0.000315	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CACNA1C—endogenous depression	3.5e-05	0.000313	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TPH2—endogenous depression	3.49e-05	0.000312	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CACNB2—endogenous depression	3.49e-05	0.000312	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—DPYD—endogenous depression	3.46e-05	0.00031	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—DPYD—endogenous depression	3.43e-05	0.000307	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP2D6—endogenous depression	3.42e-05	0.000307	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CACNA1C—endogenous depression	3.41e-05	0.000306	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—endogenous depression	3.36e-05	0.000301	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CACNA1C—endogenous depression	3.22e-05	0.000288	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CACNA1C—endogenous depression	3.19e-05	0.000286	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—endogenous depression	3.07e-05	0.000275	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP2D6—endogenous depression	3.06e-05	0.000274	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TPH1—endogenous depression	3.03e-05	0.000272	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP2D6—endogenous depression	2.98e-05	0.000267	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TPH2—endogenous depression	2.98e-05	0.000267	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CACNB2—endogenous depression	2.98e-05	0.000267	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—POMC—endogenous depression	2.97e-05	0.000266	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—DPYD—endogenous depression	2.93e-05	0.000262	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—COMT—endogenous depression	2.83e-05	0.000254	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MAOA—endogenous depression	2.81e-05	0.000252	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP2D6—endogenous depression	2.79e-05	0.00025	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CACNA1C—endogenous depression	2.72e-05	0.000244	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—POMC—endogenous depression	2.7e-05	0.000242	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.62e-05	0.000235	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—COMT—endogenous depression	2.59e-05	0.000232	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MAOA—endogenous depression	2.58e-05	0.000231	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2D6—endogenous depression	2.38e-05	0.000213	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—COMT—endogenous depression	2.32e-05	0.000207	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MAOA—endogenous depression	2.3e-05	0.000206	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TPH2—endogenous depression	2.3e-05	0.000206	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CACNB2—endogenous depression	2.3e-05	0.000206	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DPYD—endogenous depression	2.26e-05	0.000203	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—COMT—endogenous depression	2.26e-05	0.000202	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MAOA—endogenous depression	2.24e-05	0.000201	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—COMT—endogenous depression	2.13e-05	0.000191	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MAOA—endogenous depression	2.11e-05	0.000189	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—COMT—endogenous depression	2.11e-05	0.000189	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CACNA1C—endogenous depression	2.1e-05	0.000188	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MAOA—endogenous depression	2.1e-05	0.000188	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2D6—endogenous depression	1.84e-05	0.000165	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—POMC—endogenous depression	1.83e-05	0.000164	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—COMT—endogenous depression	1.8e-05	0.000162	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MAOA—endogenous depression	1.79e-05	0.000161	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—POMC—endogenous depression	1.68e-05	0.00015	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—POMC—endogenous depression	1.5e-05	0.000134	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—POMC—endogenous depression	1.46e-05	0.000131	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—COMT—endogenous depression	1.39e-05	0.000125	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MAOA—endogenous depression	1.38e-05	0.000124	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—POMC—endogenous depression	1.38e-05	0.000123	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—POMC—endogenous depression	1.37e-05	0.000122	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—POMC—endogenous depression	1.17e-05	0.000105	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—POMC—endogenous depression	9e-06	8.07e-05	CbGpPWpGaD
